[Press Alert] Safety and efficacy results of LIS1
June 2022. # Download our press information (english version) # Télécharger notre...
Read More[ Press Information ] APPOINTMENTS
April 2022. # Download our press information (english version) # Télécharger notre...
Read More[Press information] XENOTHERA announces the continuation of development of its anti-SARS-CoV-2 antibody.
January 2022. # Download our press information (english version) # Télécharger notre...
Read More[ Press Information ]The French biotech XENOTHERA awarded Start-Up of the Year for the Western region.
# Download our press information (english version) # Télécharger notre information presse...
Read More[Newsletter] XENONEWS
October 2021 >> Official XENOTHERA’s newsletter /Lettre d’information officielle de XENOTHERA <<...
Read More[Press Release] Accelarated Scientific Advise from European Medicines Adgency EMA for XAV19 Market Authorisation
July 8, 2021. # Download our press release (english version) # Télécharger...
Read More[Newsletter] XENONEWS
Summer 2021. >> Official XENOTHERA newsletter /Lettre d’information officielle de XENOTHERA <<...
Read More[Press Alert] XENOTHERA signs a pre-order contract of its anti-covid treatment with the French government
May 11, 2021. # Download our press information (english version) # Télécharger...
Read More[Newsletter] XENONEWS
May 2021 >> Official XENOTHERA newsletter /Lettre d’information officielle de XENOTHERA <<...
Read More[Press Alert] XENOTHERA And Its Partner Excelya Announce the Recruitment of the First Patient in The EUROXAV Clinical Trial of its COVID Treatment XAV19
May 3, 2021. # Download our press information (english version) # Télécharger...
Read More[Newsletter] XENONEWS
April 2021 >> Official XENOTHERA newsletter /Lettre d’information officielle de XENOTHERA <<...
Read More[Press Release] Completion of patients’ enrolment in the POLYCOR clinical trial promoted by the Nantes University Hospital
April 21, 2021. # Download our press release (english version) # Télécharger...
Read More[Newsletter] XENONEWS
February 2021 >> Official XENOTHERA newsletter /Lettre d’information officielle de XENOTHERA <<...
Read More[Newsletter] XENONEWS
January 2021 >> Official XENOTHERA newsletter /Lettre d’information officielle de XENOTHERA <<...
Read More[Press Alert] Omicron Variant : positive results for XENOTHERA's XAV-19 antibody
December 2021. # Download our press information (english version) # Télécharger notre...
Read More[Press Release] XAV19 : validation of the first dose of anti-Covid treatment of XENOTHERA
November 12, 2020. # Download our press release (english version) # Télécharger...
Read More[Infography/Infographie] Covid19
# 5 KEY POINTS TO KNOW ABOUT ANTIBODIES # Available here #...
Read More[Newsletter- 9] NEWS/INFOS
September 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19 <<...
Read More[Press Alert] XENOTHERA obtains authorization from ANSM to start the clinical trial of XAV19, its anti Covid treatment
August 10, 2020. # Download our press release (english version) # Télécharger...
Read More[Press Alert] XENOTHERA, Nantes University Hospital and the University of Nantes announce the signature of a consortium agreement within the framework of PSPC-COVID.
July 15, 2020. # Download our press release (english version) # Télécharger...
Read More[Newsletter - 8] NEWS/INFOS
July 17,2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19 <<...
Read More[Newsletter - 7] NEWS/INFOS
June 26, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...
Read More[Alerte actualité] Financement XENOTHERA
15 Juin 2020. Download the press release /Télécharger le communiqué
Read More[Newsletter-6] NEWS/INFO
June 15, 2020. >> Breaking news / Edition spéciale << Download our...
Read More